ACCENDRA HEALTH INC/VA/(ACH)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ACCENDRA HEALTH INC/VA/ (ACH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACH at 30.3/100 on a 32-signal composite quality model, placing it at rank #2,497 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.1) and free cash flow (14.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), ACCENDRA HEALTH INC/VA/ reports quarterly revenue of $613.2M, net income of $-89.1M, free cash flow of $-73.6M. Top institutional holders of ACH by reported 13-F value include Coliseum Capital Management, BlackRock, BANK OF AMERICA, based on the most recent SEC filings. ACH trades on the NYSE exchange and files with the SEC under CIK 75252. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACCENDRA HEALTH INC/VA/ directly from SEC EDGAR.